Mar 31, 2019

Neurocrine Biosciences Q1 2019 Earnings Report

Total Revenue
$138M
Previous year: $71.1M
+94.7%
EPS
-$1.12
Previous year: -$0.47
+138.3%
R&D Expense
$37.7M
SG&A Expense
$87.5M
Gross Profit
$137M
Previous year: $70.1M
+95.7%
Cash and Equivalents
$72.8M
Previous year: $175M
-58.5%
Free Cash Flow
-$116M
Previous year: -$40.3M
+188.9%
Total Assets
$958M
Previous year: $806M
+18.8%

Neurocrine Biosciences

Neurocrine Biosciences

Neurocrine Biosciences Revenue by Segment